Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 4/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.48 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 6/20 | 0.45 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.45 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.45 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.36 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.35 |
| ▸ | KDM5C | P41229 | 3/20 | 0.33 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.33 |
| ▸ | KDM2A | Q9Y2K7 | 3/20 | 0.33 |
| ▸ | KDM6B | O15054 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2402800 | 0.82 | EGLN1 (0.50) | EGLN1MAPK1SLC13A3OR51E2LMNA | |
| SCHEMBL118022 | 0.78 | FAAH (0.47) | EGLN1MAPK1SLC13A3OR51E2LMNA | |
| SCHEMBL3682948 | 0.76 | EGLN1 (0.55) | EGLN1MAPK1SLC13A3OR51E2LMNA | |
| SCHEMBL4445881 | 0.75 | FFAR3 (0.44) | EGLN1MAPK1SLC13A3OR51E2LMNA | |
| SCHEMBL125702 | 0.74 | EGLN1 (0.52) | EGLN1MAPK1SLC13A3OR51E2LMNA | |
| SCHEMBL1237232 | 0.74 | LMNA (0.50) | EGLN1MAPK1SLC13A3OR51E2LMNA | |
| SCHEMBL9668021 | 0.72 | EGLN1 (0.50) | EGLN1MAPK1SLC13A3OR51E2LMNA | |
| SCHEMBL28443284 | 0.72 | EGLN1 (0.50) | EGLN1MAPK1SLC13A3OR51E2LMNA | |
| Succinic Acid SCHEMBL1462994 | 0.71 | — | — | |
| Succinic Acid SCHEMBL17611021 | 0.71 | LMNA (0.90) | EGLN1MAPK1SLC13A3OR51E2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120322906-A1 | POLYMER AND METHODS OF PREPARING AND USING A POLYMER | CARGILL, INCORPORATED (US) | 2012-12-20 | — | — | US | disclosed |
| WO-2012166406-A1 | INCREASING PRODUCT YIELD AND/OR THROUGHPUT BY SUPERSATURATION OF SUBSTRATE | CARGILL, INCORPORATED (US) | 2012-12-06 | — | — | WO | disclosed |
| WO-2012166842-A1 | INCREASING PRODUCT YIELD AND/OR THROUGHPUT BY SUPERSATURATION OF SUBSTRATE | CARGILL, INCORPORATED (US) | 2012-12-06 | — | — | WO | disclosed |
| EP-2519406-A1 | A POLYMER AND METHODS OF PREPARING AND USING A POLYMER | Cargill, Incorporated (US) | 2012-11-07 | — | — | EP | disclosed |
| US-20120270281-A1 | BIOREACTOR PERFORMANCE IN THE PRODUCTION OF MONATIN | CARGILL, INCORPORATED (US) | 2012-10-25 | — | — | US | disclosed |
| US-20120264948-A1 | MEMBRANE SEPARATION AND PURIFICATION OF MONATIN | CARGILL, INCORPORATED (US) | 2012-10-18 | — | — | US | disclosed |
| CN-102686391-A | A polymer and methods of preparing and using a polymer | CARGILL INC | 2012-09-19 | — | — | CN | disclosed |
| WO-2011082365-A2 | IMPROVED BIOREACTOR PERFORMANCE IN THE PRODUCTION OF MONATIN | CARGILL, INCORPORATED (US) | 2011-07-07 | — | — | WO | disclosed |
| WO-2011082353-A1 | SEPARATION AND PURIFICATION OF MONATIN | CARGILL, INCORPORATED (US) | 2011-07-07 | — | — | WO | disclosed |
| WO-2011082363-A1 | MEMBRANE SEPARATION AND PURIFICATION OF MONATIN | CARGILL, INCORPORATED (US) | 2011-07-07 | — | — | WO | disclosed |
| WO-2011082351-A1 | A POLYMER AND METHODS OF PREPARING AND USING A POLYMER | CARGILL, INCORPORATED (US) | 2011-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264948-A1 | MEMBRANE SEPARATION AND PURIFICATION OF MONATIN | MON2, STOM, MLEC | EGLN1 4766/4885MAPK1 4405/4885SLC13A3 431/4885 |
| US-20120322906-A1 | POLYMER AND METHODS OF PREPARING AND USING A POLYMER | MON2, STOM, LCP1 | EGLN1 3704/4885MAPK1 2443/4885SLC13A3 2555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.